Successful medical treatment of cutaneous aspergillosis in a premature infant using liposomal amphotericin B, voriconazole and micafungin Academic Article uri icon

Overview

MeSH Major

  • Antifungal Agents
  • Aspergillosis
  • Dermatomycoses
  • Infant, Premature, Diseases

abstract

  • Treatment options for primary cutaneous aspergillosis in neonates are limited by the lack of pharmacokinetic and safety data of newer antifungal agents that are effective against Aspergillus spp. We report the successful treatment of cutaneous aspergillosis in an extremely low-birth-weight preterm infant with liposomal amphotericin B, voriconazole and micafungin, and provide pharmacokinetic profiles for voriconazole and micafungin.

publication date

  • April 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.inf.0000258698.98370.89

PubMed ID

  • 17414408

Additional Document Info

start page

  • 364

end page

  • 6

volume

  • 26

number

  • 4